Severe Electrolyte Deficiency in Cancer Treatment
Author Information
Author(s): Katrin Hoffmann, Angela Marten, Katja Lindel, Stefan Fritz, Dirk Jager, Markus W Buchler, Jan Schmidt
Primary Institution: University of Heidelberg
Hypothesis
Does low-dose Cisplatin combined with 5-Fluorouracil and Interferon alpha lead to severe hypocalcaemia in pancreatic cancer patients?
Conclusion
The combination of biological and cytotoxic therapies may increase the incidence of severe hypocalcaemia in pancreatic cancer.
Supporting Evidence
- 15 of 23 patients treated developed moderate to severe hypocalcaemia.
- Calcium levels declined significantly within 2 days after the fourth week of treatment.
- Patients showed no signs of acute renal failure during the study.
Takeaway
Some cancer treatments can make your body lose important minerals like calcium, which can make you very sick.
Methodology
The study involved 23 patients with pancreatic cancer treated with a combination of low-dose Cisplatin, 5-Fluorouracil, Interferon alpha, and external beam radiation.
Potential Biases
Potential bias due to the lack of randomization and the observational nature of the study.
Limitations
The study is limited by the small sample size and the lack of a control group.
Participant Demographics
Median age of participants was 60 years, with 29 males and 18 females.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website